My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Allocation Agreement with exhibits - final
>
Meetings
>
2022
>
09. September
>
2022-09-06 10:00 AM - Commissioners' Agenda
>
Allocation Agreement with exhibits - final
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
9/1/2022 1:11:41 PM
Creation date
9/1/2022 1:10:08 PM
Metadata
Fields
Template:
Meeting
Date
9/6/2022
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Supporting documentation
Supplemental fields
Item
Request to Approve a Resolution Authorizing the Chair's Signature on a Opioid Litigation Allocation Agreement
Order
3
Placement
Consent Agenda
Row ID
93293
Type
Agreement
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
106
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
11 <br />strategies to abate the opioid epidemic described in this opioid abatement strategy list <br />(e.g., health care, primary care, pharmacies, PDMPs, etc.). <br />L.RESEARCH <br />Support opioid abatement research that may include, but is not limited to, the following: <br />1.Monitoring, surveillance, and evaluation of programs and strategies described in this <br />opioid abatement strategy list. <br />2.Research non-opioid treatment of chronic pain. <br />3.Research on improved service delivery for modalities such as SBIRT that demonstrate <br />promising but mixed results in populations vulnerable to opioid use disorders. <br />4.Research on innovative supply-side enforcement efforts such as improved detection of <br />mail-based delivery of synthetic opioids. <br />5.Expanded research on swift/certain/fair models to reduce and deter opioid misuse <br />within criminal justice populations that build upon promising approaches used to <br />address other substances (e.g. Hawaii HOPE and Dakota 24/7). <br />6.Research on expanded modalities such as prescription methadone that can expand <br />access to MAT.
The URL can be used to link to this page
Your browser does not support the video tag.